optimainsights-post

[optimainsights-post]

Urinary Stones Treatment Devices Market to Grow at 4.4% CAGR to Reach US$1.98 billion by 2026

The Global Urinary Stones Treatment Devices Market was valued at US$1.48 billion in the year 2018 and is expected to reach US$1.98 billion by 2026, at a CAGR of 4.4%.

 Urinary stones are mainly formed due to the inability of an individual to empty the urinary bladder. Due to urine accumulation, the minerals in the concentrated urine start crystalizing leading to the formation of stones. Depending on the location of the stone development it may be classified as a kidney stone, bladder stone or ureteral stone. These stones are diagnosed using, abdominal X-ray, CT scan, MRI scan, ultrasound, etc. During the early days, the stones were removed through surgical procedures. But the development of technologies such as lithotripsy, ureteroscopy, nephrolithotomy had reduced the hurdles in treatment and the removal of urinary stones. Also growing popularity of digital flexible ureteroscopes and rising focus on the development of lasers alternative to conventional once are the factors that contribute to the market growth.

Urolithiasis and Nephrolithiasis are the main conditions that contribute to the development of kidney stones in individuals and chiefly contribute to market growth. Besides, the recurrence of kidney stones in the adult population has also risen to 50% in recent decades due to enormous changes in the lifestyle, poor dietary habits, an increase in obesity, less intake of water and many other associated morbidities. Moreover, as recent research suggested, the probability of recurrence of nephrolithiasis in adolescents or children is about 50% within 3 years of the first occurrence. According to the National Kidney Foundation, over half a million people across the globe visit emergency rooms every year. International Federation of Kidney Foundations and the International Society of Nephrology are taking several initiatives to create awareness among the people regarding the equitable and inexpensive access to treatment options, screening, and diagnosis. This is set to drive the Urinary Treatment Devices market during the forecast period.

Implementation of imaging technologies for scanning urinary stones is expected to drive the growth in the upcoming years. Among diagnoses, the ultrasound segment emphasizes reducing the amount of ionizing radiation delivered to patients during routine imaging. It has also become a mainstay tool in the urologists' armamentarium for the diagnosis and management of nephrolithiasis. New advancements in ultrasound technology had also facilitated its use as a therapeutic and therapy guidance aid. Ultrasound is being used as the first line for the diagnosis of urinary stones for more than 14 years and is set to grow with a healthy CAGR of 5.1% during the forecast period. Other diagnostic techniques such as MRI, intravenous pyelogram, non-contrast CT are said to contribute very little when compared to ultrasound.

 Adoption of an alternative way of treatment such as Chinese herbal medicine, Ayurveda, acupressure was minimal during the yesteryears. However, after the rediscovery of the ancient techniques, the options for treating urinary stones with herbal medicine, acupressure, etc. are being researched more and few options have also become successful in minimizing the urinary stones. This is set to hamper the market growth as WHO had already initiated a global level initiative to study and standardize the usage of medicinal plants including that of the folklore medicine.

 However modern medicine offers an effective way of treatment. Among them, the lithotripsy segment has a huge demand in the market treating urinary stones and also to sidestep the invasive surgical procedures that were used for stone removal. Lithotripsy uses ultrasonic energy or shock waves focused directly on the stone to identify the place which was previously located with fluoroscopy or ultrasound of the stones. The patient is positioned in such a way so that the stones are targeted precisely. By using this lithotripsy, the complications, hospital stays, costs and recovery time are reduced. The treatment using lithotripsy is expected to fuel market growth until 2026.

 Among stone types, the calcium oxalate segment has been reported to propel the urinary stones market till 2018. The formation of calcium oxalate stones is strongly linked to the consumption of foods consisting high amount of oxalate that naturally occurs in plants and animals. This includes beets, black tea, chocolate, nuts, potatoes, and spinach. Also, calcium in the form of supplements for several other bone-related disorders may increase the chances of forming new calcium oxalate stones in the urine. Also, consumption of more leguminous foods such as dried beans, peas, anchovies and drinking of beer may increase the chances of uric acid crystal formation due to the deposition of purines in the kidney.

 North American region highly dominates the urinary stones treatment devices market due to extensive prevalence in the occurrence of urinary stones. The favorable conditions for research and development, increased healthcare expenditure and growing utilization of advanced technology for the treatment aspects are evident in this region. The US market holds a market share of about 65% to 35% whereas the Canadian market share is set to increase by around 2% during the forthcoming years due to more immigration from other countries. Further, government initiatives towards strengthening the healthcare infrastructure are accelerating the growth of the urinary stone treatment devices market in this region. Followed by the North American region is the European region, where Germany alone contributes to more than 27% of the total European market growth due to more occurrence of Urolithiasis among German individuals followed by France, the UK, Italy, and Spain. Besides, the Asia Pacific and the Middle East countries are also expected to contribute to the market growth having potential opportunities falling under the kidney stone belt of the world.

 Some of the key players in the urinary stones treatment devices market are, Becton, Dickinson and Company, Boston Scientific Corporation, EDAP TMS S.A., Olympus Corporation, Coloplast A/S, Siemens Healthineers, Convergent Laser Technologies, Cook Medical Inc, Direx Group, Dornier MedTech GmbH, Elmed Electronics & Medical Industry & Trade Inc, KARL STORZ GmbH & Co. KG, Lumenis Ltd, Medispec LTD, Richard Wolf Medical Instruments Corporation, Allengers Medical Systems Ltd and E.M.S. Electro Medical Systems SA.

 Request for Sample Pages @ https://www.optimainsights.org/sample-request/145-urinary-stones-treatment-devices-market

Key Updates:

FDA Approves Retrophin’s New Formula Thiola EC (tiopronin) for treating Cystine Kidney Stones

Dornier’s new Gemini stone-busting system:  The pulverizer is both a step into the future and a blast from the past

Dornier launches AXIS™ Single-Use Digital Ureteroscope for treating Urinary Stones

Journal Summaries in Internal Medicine: Researchers examined the utility of experimental Thulium fiber laser (TFL) as an alternative to the gold standard Holmium: YAG laser for lithotripsy

The Report Provides Key Insights on

History of the Urinary Stones Treatment Devices Market, 2015 to 2017

Forecast of the Urinary Stones Treatment Devices Market Growth till the year 2026

The key market drivers, restraints, challenges, future opportunities and the market dynamics driving the Urinary Stones Treatment Devices Market

Analysis of potential growth segments which will drive the market

Landscape analysis of the major companies, and new market entrants and companies which possess disruptive technologies which can change the trend of the entire market

Key market approaches adopted by the organizations and in-depth intelligence of potential strategies which could alter the market dynamics

Urinary Stones Treatment Devices Market Based on Diagnosis (Market Size and Forecast, and Y-o-Y Growth, (US$ Mn)

·         Abdominal X-Ray

·         Computed Tomography(CT) Scan

·         Intravenous Pyelography (IVP)

·         Ultrasound

·         Abdominal MRI

Urinary Stones Treatment Devices Market Based on Treatment (Market Size and Forecast, and Y-o-Y Growth, (US$ Mn)

·         Percutaneous Nephrolithotomy (PCNL)

·         Ureteroscopy (URS)

·         Extracorporeal Shock Wave Lithotripsy (ESWL)

Urinary Stones Treatment Devices Market Based on Stone Type (Market Size and Forecast, and Y-o-Y Growth, (US$ Mn)

·         Calcium Phosphate

·         Cystine

·         Struvite

·         Uric Acid

·         Calcium Oxalate

Urinary Stones Treatment Devices Market Based on Geographic Region (Market Size and Forecast, and Y-o-Y Growth, (US$ Mn)

·         North America

·         Europe

·         APAC

·         LAMEA

Urinary Stones Treatment Devices Market Competitive Analysis (Company Overview, SWOT Matrix, Financial, Product Overview, and Market Strategies)

·         Siemens Healthineers

·         Direx Systems Corp

·         Dornier Medtech Gmbh

·         Elmed Electronics & Medical Industry & Trade Inc

·         Karl Storz Gmbh & Co. KG

·         Lumenis Ltd

·         Medispec Ltd

·         E.M.S. Electro Medical Systems SA

 Download Complete TOC of the Report @ https://www.optimainsights.org/request-toc/145-urinary-stones-treatment-devices-market

 About Us

Optima Insights is an innovative research and insights-driven enterprise committed to offering actionable intelligence to the global life science and healthcare market. We believe that meaningful insights and improved strategic content hold the key to improved ROI for our clients. We strike an innovative engagement model with our clients to Co-Create Intelligence that would address very specific issues facing them within their functional areas. We continuously support clients through the entire journey map to enable them to make better business decisions towards attaining market leadership.

 Contact

Optima Insights

Mr. Chucks G

+91 966 6620 365 (Asia) | +1 424 2554 365 (US)

Email: Sales@optimainsights.org

https://www.optimainsights.org

[optimainsights-post]

The Global Multiple Myeloma Treatment Market was valued at US$10.9 billion in the year 2018 and is likely to reach US$17.5 billion by 2026, with a CAGR of 6.1%.

[optimainsights-post]

Sickle Cell Anemia Therapeutics Market

Sickle Cell Anemia depending on treatment, hydroxyurea segment is expected to account for the largest share of the Sickle Cell Anemia market due to increasing the level of hemoglobin in the body. And, if taken regularly, it may help to reduce the number of symptoms such as pain episodes and acute chest syndrome. It recommended for the patients having moderate to severe pain episodes in a 12-month period, a history of stroke and a contraindication to chronic transfusions and a history of acute chest syndrome or symptomatic anemia

[optimainsights-post]

Wish you a Merry Christmas and may this festival bring abundant joy and happiness in your life!

[optimainsights-post]

The Global Allergy Immunotherapy market is diversifying at a good pace due to a surge in allergy incidents across the globe. The overall Global Allergy Immunotherapy Market is expected to grow at a significant CAGR rate of 9.61% from USD 1.07 billion in 2018 to USD 2.23 billion in 2026. This expansion in allergy immunotherapy is due to an increase in awareness of allergy treatment, growth in allergic population and new product launch. Allergy Immunotherapy is also referred to as desensitization ...

Allergy Immunotherapy Market

[optimainsights-post]

The Global Allergy Immunotherapy market is diversifying at a good pace due to a surge in allergy incidents across the globe. The overall Global Allergy Immunotherapy Market is expected to grow at a significant CAGR rate of 9.61% from USD 1.07 billion in 2018 to USD 2.23 billion in 2026. This expansion in allergy immunotherapy is due to an increase in awareness of allergy treatment, growth in allergic population and new product launch. Allergy Immunotherapy is also referred to as desensitization ...

Allergy Immunotherapy Market

[optimainsights-post]

The global allergy immunotherapy expansion is attributed to the increase in awareness regarding allergy treatment, the launch of new products, and rapidly growing allergic population. https://bit.ly/2OTKNzL

[optimainsights-post]

The Chinese biopharmaceutical industry is actively investing in both the biologics pipeline for innovative domestic products and the bio-manufacturing infrastructure needed to commercialize these innovations.

[optimainsights-post]

The prevailing cases of diabetes are mainly due to the rise in obesity levels, which is mainly because of their sedentary lifestyles, physical inactivities, unhealthy eating habits, and an increasi...

[optimainsights-post]

Oral Insulin Therapies Market Outlook to 2026 | Global Market Size, Share, Trends, Outlook, Opportunity Analysis, Forecast, and Estimates

Insulin by pill… our featured podcast is about new technology being developed to deliver oral doses of insulin. Amazingly, it was inspired by the self-righting leopard tortoise: http://bit.ly/2tXGqtx 

 Image Credit: Felice Frankel/MIT

[optimainsights-post]

[optimainsights-post]

[optimainsights-post]

The current treatment paradigm for most hemophilia patients remains predominantly first-generation recombinant factor replacement therapies. Recombinant products now represent two third of the market. Prior to the development of recombinant technologies, plasma-derived therapies remained the standard of care

[optimainsights-post]

Ostomy care products support patients with a stoma. A stoma is created in response to an intestinal dysfunction which results from disease, accident or congenital disorder. The stoma is a surgically created opening in the abdominal wall providing a means for waste to leave the body. The main reason for such surgeries is cancer.

[optimainsights-post]

This report studies the polymerase chain reaction technology market status and outlook of global and major regions, from angles of players, countries, product types and end industries

[optimainsights-post]

The reports study the sexually transmitted disease therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in the global market and splits the Sexually Transmitted Disease Therapeutics market by product type and applications/end industries.

[optimainsights-post]

Circulating tumor cells tests are applicable in the characterization of tumor cells through biochemical marker analysis. CTC isolation, detection, and molecular characterization systems find investigational application in all kind of cancer